Neuphoria Therapeutics Inc. - Common Stock (NEUP)

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Neuphoria Therapeutics Inc. (NASDAQ: NEUP) and Scancell Holdings plc. Upon closing of the proposed transaction, Neuphoria shareholders will own 14.5% of the combined company.

Myseum Inc. (NASDAQ: MYSE), a privacy-first social media and technology innovator, is capturing investor and media attention this week as CEO Darin Myman takes to the airwaves, sharing his vision for how Myseum’s technology could dramatically disrupt the social media landscape as we know it. The market has taken notice. MYSE shares have been active this week , closing Wednesday, October 22, 2025, at $2.68 and surging to an intraday high of $3.07 on Thursday on strong volume — reflecting growing investor enthusiasm as the company’s technology gains wider recognition.